Evidence map›Paper›PMID 42461037›Full record

ArticleApplied and environmental microbiology2026

Leucine auxotrophic marker for genetic manipulation of

Tizian Griesser, Petra Selchow, Peter Sander

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tizian GriesserInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.ORCID 0009-0002-8297-461X
Petra SelchowInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-8305-3316
Peter SanderInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-1581-0682

Funding

Cystische Fibrose Schweiz (CFCH) 2035416Federal Office of Public Health 3643080304Joint Programming Initiative on Antimicrobial Resistance 2022-050Swiss National Science Foundation 310030-197699/1
6 · The paper itself

Abstract

IMPORTANCE: The development of a leucine auxotroph-based genetic system for

Indexed as

LeucineMycobacterium abscessus3-Isopropylmalate DehydrogenaseBacterial ProteinsGene DeletionGenetic VectorsPlasmids3-Isopropylmalate DehydrogenaseBacterial ProteinsLeucineaminoglycoside resistanceauxotrophic markergenetic toolleucine auxotrophMycobacterium abscessus

Identifiers

PMID42461037
PMCPMC13488338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.